FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327733117> ?p ?o ?g. }

• W4327733117 abstract "Malignant pleural mesothelioma (MPM) is a rare and highly aggressive thoracic tumor with poor prognosis and limited therapeutic options. Although immune checkpoint inhibitors exhibit a promising effect in some patients with unresectable MPM in clinical trials, the majority of MPM patients show only modest response rates to the currently available treatments. It is thus imperative to develop novel and innovative therapeutic modalities for MPM, including immune effector cell-based therapies.γδ T cells were expanded using tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino) ethylidene-1,1-bisphosphonate (PTA) and interleukin-2, and the therapeutic potential of γδ T cells was examined through analyzing cell surface markers and cellular cytotoxicity against MPM in vitro using a europium chelate-based time-resolved fluorescence assay system and a luciferase-based luminescence assay system.We successfully expanded γδ T cells from peripheral blood mononuclear cells of healthy donors and MPM patients. γδ T cells expressed natural killer receptors such as NKG2D and DNAM-1 and exhibited a moderate level of cytotoxicity to MPM cells in the absence of antigens. The inclusion of PTA, (E)-4-hydroxy-3- methylbut-2-enyl diphosphate (HMBPP) or zoledronic acid (ZOL) induced a TCR-dependent cytotoxicity in γδ T cells and secreted interferon-γ (IFN-γ). In addition, γδ T cells expressing CD16 exhibited a significant level of cytotoxicity against MPM cells in the presence of an anti-epidermal growth factor receptor (EGFR) mAb, at lower concentrations than in clinical settings, whereas a detectable level of IFN-γ was not produced. Taken together, γδ T cells showed cytotoxic activity against MPM in three distinct mechanisms through NK receptors, TCRs and CD16. Since major histocompatibility complex (MHC) molecules are not involved in the recognition, both autologous and allogeneic γδ T cells could be used for the development of γδ T cell-based adoptive immunotherapy for MPM." @default.
• W4327733117 created "2023-03-18" @default.
• W4327733117 creator A5021321317 @default.
• W4327733117 creator A5024606605 @default.
• W4327733117 creator A5027171470 @default.
• W4327733117 creator A5053910732 @default.
• W4327733117 creator A5071159100 @default.
• W4327733117 creator A5075807220 @default.
• W4327733117 creator A5076225179 @default.
• W4327733117 creator A5077110924 @default.
• W4327733117 creator A5082056968 @default.
• W4327733117 creator A5082897973 @default.
• W4327733117 creator A5086521398 @default.
• W4327733117 date "2023-03-17" @default.
• W4327733117 modified "2023-09-25" @default.
• W4327733117 title "Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma" @default.
• W4327733117 cites W1972120590 @default.
• W4327733117 cites W1978327177 @default.
• W4327733117 cites W1992794673 @default.
• W4327733117 cites W1994993231 @default.
• W4327733117 cites W2002025804 @default.
• W4327733117 cites W2008096858 @default.
• W4327733117 cites W2017453418 @default.
• W4327733117 cites W2028539126 @default.
• W4327733117 cites W2063096720 @default.
• W4327733117 cites W2073312795 @default.
• W4327733117 cites W2102627969 @default.
• W4327733117 cites W2116738410 @default.
• W4327733117 cites W2127367385 @default.
• W4327733117 cites W2139403967 @default.
• W4327733117 cites W2153901715 @default.
• W4327733117 cites W2164756833 @default.
• W4327733117 cites W2292766007 @default.
• W4327733117 cites W2748981056 @default.
• W4327733117 cites W2752877239 @default.
• W4327733117 cites W2767999152 @default.
• W4327733117 cites W2777644429 @default.
• W4327733117 cites W2792541584 @default.
• W4327733117 cites W2794124550 @default.
• W4327733117 cites W2903062212 @default.
• W4327733117 cites W2949290496 @default.
• W4327733117 cites W2966041852 @default.
• W4327733117 cites W2998735059 @default.
• W4327733117 cites W3006756187 @default.
• W4327733117 cites W3018674756 @default.
• W4327733117 cites W3033381060 @default.
• W4327733117 cites W3043437819 @default.
• W4327733117 cites W3084016555 @default.
• W4327733117 cites W3084540419 @default.
• W4327733117 cites W3087001896 @default.
• W4327733117 cites W3106876990 @default.
• W4327733117 cites W3122627530 @default.
• W4327733117 cites W3154654785 @default.
• W4327733117 cites W3164213044 @default.
• W4327733117 cites W3166050533 @default.
• W4327733117 cites W3170563044 @default.
• W4327733117 cites W3193921772 @default.
• W4327733117 cites W3212093519 @default.
• W4327733117 cites W4200305256 @default.
• W4327733117 cites W4200527716 @default.
• W4327733117 cites W4206410601 @default.
• W4327733117 cites W4213012803 @default.
• W4327733117 cites W4220857039 @default.
• W4327733117 cites W4220893473 @default.
• W4327733117 cites W4253181009 @default.
• W4327733117 doi "https://doi.org/10.3389/fimmu.2023.1058838" @default.
• W4327733117 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37006249" @default.
• W4327733117 hasPublicationYear "2023" @default.
• W4327733117 type Work @default.
• W4327733117 citedByCount "0" @default.
• W4327733117 crossrefType "journal-article" @default.
• W4327733117 hasAuthorship W4327733117A5021321317 @default.
• W4327733117 hasAuthorship W4327733117A5024606605 @default.
• W4327733117 hasAuthorship W4327733117A5027171470 @default.
• W4327733117 hasAuthorship W4327733117A5053910732 @default.
• W4327733117 hasAuthorship W4327733117A5071159100 @default.
• W4327733117 hasAuthorship W4327733117A5075807220 @default.
• W4327733117 hasAuthorship W4327733117A5076225179 @default.
• W4327733117 hasAuthorship W4327733117A5077110924 @default.
• W4327733117 hasAuthorship W4327733117A5082056968 @default.
• W4327733117 hasAuthorship W4327733117A5082897973 @default.
• W4327733117 hasAuthorship W4327733117A5086521398 @default.
• W4327733117 hasBestOaLocation W43277331171 @default.
• W4327733117 hasConcept C109316439 @default.
• W4327733117 hasConcept C154317977 @default.
• W4327733117 hasConcept C185592680 @default.
• W4327733117 hasConcept C202751555 @default.
• W4327733117 hasConcept C203014093 @default.
• W4327733117 hasConcept C2778867473 @default.
• W4327733117 hasConcept C502942594 @default.
• W4327733117 hasConcept C55493867 @default.
• W4327733117 hasConcept C71924100 @default.
• W4327733117 hasConcept C86803240 @default.
• W4327733117 hasConcept C8891405 @default.
• W4327733117 hasConceptScore W4327733117C109316439 @default.
• W4327733117 hasConceptScore W4327733117C154317977 @default.
• W4327733117 hasConceptScore W4327733117C185592680 @default.
• W4327733117 hasConceptScore W4327733117C202751555 @default.
• W4327733117 hasConceptScore W4327733117C203014093 @default.
• W4327733117 hasConceptScore W4327733117C2778867473 @default.

• next